Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Vineet Laboratories Limited
No Price
Closing Price XNSE 29.04.2026:
38,55 INR
29.04.2026 09:59
Current Prices from Vineet Laboratories Limited
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NSE
VINEETLAB.NS
INR
29.04.2026 09:59
38,55 INR
2,11 INR
+5,79 %
MSE
VINEETLAB.BO
INR
29.04.2026 09:59
38,83 INR
2,39 INR
+6,56 %
Share Float & Liquidity
Free Float72,22 %
Shares Float6,68 M
Shares Outstanding9,24 M
Company Profile for Vineet Laboratories Limited Share
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients and fine chemicals in India. It offers intermediates of lopinavir, ritonavir, efavirenz, nadolol, glimepiride, celecoxib, olanine, and other API intermediates; and fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.
